Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Medtronic
Baxter
McKesson
Boehringer Ingelheim

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Canagliflozin; Metformin Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00968812 CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride Completed Janssen Research & Development, LLC Phase 3 2009-09-01 The purpose of this study is to demonstrate the efficacy, safety, and tolerability of canagliflozin (JNJ-28431754) compared with glimepiride in patients with type 2 diabetes mellitus with inadequate control despite treatment with metformin.
NCT01081834 The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial Completed Janssen Research & Development, LLC Phase 3 2010-03-01 The purpose of this study is to evaluate the efficacy, safety, and tolerability of 2 different doses of canagliflozin administered as monotherapy compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise.
NCT01106625 The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea) Completed Janssen Research & Development, LLC Phase 3 2010-05-01 The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are receiving treatment with metformin and sulphonylurea and have inadequate glycemic (blood sugar) control.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Canagliflozin; Metformin Hydrochloride

Condition Name

Condition Name for Canagliflozin; Metformin Hydrochloride
Intervention Trials
Diabetes Mellitus, Type 2 19
Healthy 16
Healthy Volunteers 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Canagliflozin; Metformin Hydrochloride
Intervention Trials
Diabetes Mellitus, Type 2 25
Diabetes Mellitus 25
Fatty Liver 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Canagliflozin; Metformin Hydrochloride

Trials by Country

Trials by Country for Canagliflozin; Metformin Hydrochloride
Location Trials
United States 251
Canada 25
Mexico 11
India 10
Germany 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Canagliflozin; Metformin Hydrochloride
Location Trials
Arizona 17
Florida 13
California 13
Texas 12
Ohio 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Canagliflozin; Metformin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Canagliflozin; Metformin Hydrochloride
Clinical Trial Phase Trials
Phase 4 9
Phase 3 9
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Canagliflozin; Metformin Hydrochloride
Clinical Trial Phase Trials
Completed 32
Recruiting 9
Not yet recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Canagliflozin; Metformin Hydrochloride

Sponsor Name

Sponsor Name for Canagliflozin; Metformin Hydrochloride
Sponsor Trials
Janssen Research & Development, LLC 31
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 5
University of Leicester 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Canagliflozin; Metformin Hydrochloride
Sponsor Trials
Industry 42
Other 11
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Medtronic
Johnson and Johnson
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.